REFERENCE RECONSTITUTION INFORMATION
RECOMMENDED RECONSTITUTION GUIDE This guide explains how research peptides are commonly reconstituted using bacteriostatic water (BAC water), and shows how dosing volumes correspond to syringe units.Always follow sterile preparation techniques when handling research peptides.
Always follow sterile preparation techniques when handling research peptides.
⚠️ DISCLAIMER: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
General Preparation
⚠️ Important: Allow product vial and BAC water to reach room temperature before reconstituting to reduce condensation uptake
- Use bacteriostatic water (BAC water) only
- Inject water slowly down the inside of the vial
- Do not shake the vial
- Gently swirl to dissolve the peptide powder
- Store refrigerated after mixing
- Use sterile technique when handling
Reference Handling Information
Reference information for laboratory handling of Retatrutide.
RouteSubcutaneous injectionScheduleWeekly subcutaneous injections with gradual titrationInjection SitesRotate injection sitesDosingDose Range: 2–10 mg weekly
- Use sterile technique when handling and administering
- Goal: Support significant weight reduction and metabolic improvements
- Frequency: Once weekly (use same day each week)
- Storage - Lyophilized: Store at −20 °C or below in dry, dark conditions
- Storage - Reconstituted: Refrigerate at 2–8 °C; use within 4-5 weeks
- Do not refreeze reconstituted solution
- Allow vial to reach room temperature before opening
RETATRUTIDE (40mg) - RECONSTITUTION TABLES
tandard Protocol (2ml BAC Water; 20.0 mg/ml)
WEEKDOSE PER INJECTIONUNITS (PER INJECTION) (ML)Weeks 1–42 mg10 units (0.10ml)Weeks 5–84 mg20 units (0.20ml)Weeks 9–125 mg25 units (0.25ml)Weeks 13–168 mg40 units (0.40ml)Weeks 17+10 mg50 units (0.50ml)Reference interval:Once weekly subcutaneous injection. Goal: Support weight reduction with gradual titration.These parameters are drawn from published research for reference purposes only. They do not constitute medical or dosing advice. For laboratory research only.
Standard Protocol (3ml BAC Water; 13.33 mg/ml)
WEEKDOSE PER INJECTIONUNITS (PER INJECTION) (ML)Weeks 1–42 mg15 units (0.15ml)Weeks 5–84 mg30 units (0.30ml)Weeks 9–125 mg38 units (0.38ml)Weeks 13–168 mg60 units (0.60ml)Weeks 17+10 mg75 units (0.75ml)Reference interval:Once weekly subcutaneous injection. Goal: Support weight reduction with gradual titration.These parameters are drawn from published research for reference purposes only. They do not constitute medical or dosing advice. For laboratory research only.
Experimental Study Period
STUDY PERIOD12–24 weeksWASHOUT PERIOD8–12 weeksADJUSTMENT NOTESGradual reduction recommendedRESEARCH CONTEXTPrevents metabolic adaptation and ensures sustainable weight managementThese tables show common research dosages. Always use an insulin syringe marked with units for accurate measurement. Contact our research support team for additional guidance.
